scispace - formally typeset
J

John W. Erdman

Researcher at University of Illinois at Urbana–Champaign

Publications -  329
Citations -  19074

John W. Erdman is an academic researcher from University of Illinois at Urbana–Champaign. The author has contributed to research in topics: Lycopene & Carotenoid. The author has an hindex of 65, co-authored 314 publications receiving 17580 citations. Previous affiliations of John W. Erdman include University of Oklahoma Health Sciences Center & Urbana University.

Papers
More filters
Journal ArticleDOI

Quantitative Ultrasound and the Pancreas: Demonstration of Early Detection Capability.

TL;DR: The cerulein-induced pancreatitis model can be used as a surrogate for the PCa model, particularly for detecting early responses to PCa onset/treatment, and there is high likelihood for early detection of either disease onset or response to therapy using quantitative ultrasound measures.
Journal ArticleDOI

Effect of Various Soy Protein Products on Retention of Nonheme Iron from a Casein Test Meal or from Soy‐Based Test Meals

TL;DR: In this article, the influence of soy product processing on whole-body 59Fe retention by the rat was examined and it was shown that soy protein products present in the diet prior to a casein-based radiolabeled test meal lowered iron retention relative to that by rats fed the casein diet.
Journal ArticleDOI

Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.

TL;DR: The quantitative US fat fraction estimator is more accurate than the controlled attenuation parameter in the diagnosis of hepatic steatosis in patients with or suspected of having nonalcoholic fatty liver disease.
Journal ArticleDOI

Beyond Nutrient Deficiency-Opportunities to Improve Nutritional Status and Promote Health Modernizing DRIs and Supplementation Recommendations.

TL;DR: In this paper, the authors proposed to modernize vitamin and mineral intake recommendations based on biomarker or surrogate endpoint levels needed to 'prevent deficiency' with Dietary Reference Intakes (DRIs) based on ranges of biomarkers or surrogate endpoints levels that support normal cell/organ/tissue function in healthy individuals.